Effects on fear reactivity in XO mice are due to haploinsufficiency of a non-PAR X gene: implications for emotional function in Turner's syndrome

Human Molecular Genetics
Anthony R IslesLawrence S Wilkinson

Abstract

Recent work has indicated altered emotional functioning in Turner's syndrome (TS) subjects (45,XO). We examined the role of X-chromosome deficiency on fear reactivity in X-monosomic mice (39,XO), and found that they exhibited anxiogenic behaviour relative to normal females (40,XX). A molecular candidate for this effect is Steroid sulfatase (Sts) as this is located in the pseudoautosomal region (PAR) of the X-chromosome and consequently is normally biallelically expressed. In addition, the steroid sulfatase enzyme (STS) is putatively linked to fear reactivity by an effect on GABAA receptors via the action of neurosteroids. Real-time PCR demonstrated that levels of Sts mRNA were reduced by half in the brains of 39,XO mice compared with 40,XX, and that expression levels of a number of GABAA subunits previously shown to be important components of fear processing (Gabra3, Gabra1 and Gabrg2) were also altered. However, 40,XY*X mice, in which the Y*X is a small chromosome comprising of a complete PAR and a small non-PAR segment of the X-chromosome, exhibited the same pattern of fear reactivity behaviour as 39,XO animals, but equivalent expression levels of Sts, Gabra1, Gabra3 and Gabrg2 to 40,XX females. This showed that although Sts ...Continue Reading

References

Jun 15, 1979·Science·L J ShapiroG Romeo
Jul 18, 1989·European Journal of Pharmacology·D BelelliK W Gee
Feb 1, 1995·Trends in Pharmacological Sciences·G R Dawson, M D Tricklebank
Dec 1, 1994·Journal of Pediatric Psychology·J Rovet, L Ireland
Dec 24, 1997·Nature·W Henn, K D Zang
May 16, 1998·Human Molecular Genetics·A GreenfieldP Koopman
Jul 25, 1998·Cytogenetics and Cell Genetics·P S BurgoyneA Ashworth
Aug 5, 1998·Current Opinion in Genetics & Development·A R Zinn, J L Ross
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·C M Disteche
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·L CarrelH F Willard
Apr 3, 2001·Trends in Pharmacological Sciences·U RudolphH Möhler
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 25, 2002·Human Molecular Genetics·Jun XuArthur P Arnold
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·J E KralicA L Morrow
Sep 5, 2002·Developmental Psychobiology·Cynthia S KeysorRudolf Hoehn-Saric
Sep 24, 2002·Nature Neuroscience·Laura L CarruthArthur P Arnold
Apr 18, 2003·Biology of Reproduction·Hitoshi IshikawaPaul S Burgoyne
Aug 6, 2003·Cytogenetic and Genome Research·P S BurgoyneJ M A Turner
Aug 7, 2003·Trends in Genetics : TIG·Carolyn J Brown, John M Greally
Aug 30, 2003·Neuroscience and Biobehavioral Reviews·Maria W G Nijhuis-van der SandenBarto J Otten
Mar 24, 2004·Neuroscience and Biobehavioral Reviews·M A MorganD W Pfaff

❮ Previous
Next ❯

Citations

Aug 24, 2004·Nature Reviews. Neuroscience·Arthur P Arnold
Jan 7, 2014·Frontiers in Neuroendocrinology·Kimberly H CoxEmilie F Rissman
Sep 18, 2007·Journal of Molecular Neuroscience : MN·Adam S RaefskiMichael J O'Neill
Feb 3, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Arthur P ArnoldShayna M Williams-Burris
Mar 11, 2008·Biological Psychology·André AlemanSophie van Rijn
Jun 4, 2014·Clinical Endocrinology·Ondrej SoucekZdenek Sumnik
Sep 8, 2010·Hormones and Behavior·Jun Xu, Megan Andreassi
Mar 3, 2009·Biological Psychiatry·William DaviesLawrence S Wilkinson
Jan 9, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Rhonda R VoskuhlYuichiro Itoh
Oct 24, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Andrew R ZinnJudith L Ross
Apr 6, 2005·Human Molecular Genetics·David H Skuse
Mar 3, 2009·The European Journal of Neuroscience·Xuqi ChenArthur P Arnold
Feb 20, 2019·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Arthur P Arnold
Jan 23, 2010·The European Journal of Neuroscience·Dinko RelkovicAnthony R Isles
Dec 6, 2012·Genes, Brain, and Behavior·J T WolstenholmeS Bekiranov
Aug 15, 2019·Translational Neuroscience·Trevor Humby, William Davies
Sep 26, 2019·Frontiers in Behavioral Neuroscience·Shawn M AardeJames D Jentsch
Jun 8, 2017·Neuroscience and Biobehavioral Reviews·Chenxi Zhao, Gaolang Gong
Mar 21, 2007·Behavioural Brain Research·Phoebe M Y Lynn, William Davies
Nov 26, 2008·Frontiers in Neuroendocrinology·Arthur P Arnold, Xuqi Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.